Trademark: 97672486
Word
OMEROS
Status
Pending
Status Code
688
Status Date
Tuesday, March 19, 2024
Serial Number
97672486
Mark Type
4000
Filing Date
Thursday, November 10, 2022
Published for Opposition
Tuesday, January 23, 2024

Trademark Owner History
Omeros Corporation - Owner At Publication

Classifications
44 Medical information services, namely, providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceutical products with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders
42 Providing information concerning medical and scientific research with respect to transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders

Trademark Events
Mar 19, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2024
Published For Opposition
Jan 3, 2024
Notification Of Notice Of Publication E-Mailed
Dec 14, 2023
Approved For Pub - Principal Register
Dec 12, 2023
Teas/Email Correspondence Entered
Dec 11, 2023
Correspondence Received In Law Office
Dec 11, 2023
Teas Response To Office Action Received
Dec 5, 2023
Notification Of Non-Final Action E-Mailed
Dec 5, 2023
Non-Final Action E-Mailed
Dec 5, 2023
Non-Final Action Written
Oct 16, 2023
Previous Allowance Count Withdrawn
Sep 26, 2023
Withdrawn From Pub - Og Review Query
Sep 13, 2023
Approved For Pub - Principal Register
Aug 23, 2023
Assigned To Examiner
Dec 1, 2022
New Application Office Supplied Data Entered
Nov 14, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24